Report : North America Acetaminophen Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Antibody/Substrate Reagent, Enzyme Reagent, Acetaminophen Antiserum, Acetaminophen Fluorescein Tracer, and Pretreatment Solution), Application (Enzymatic Assays and Immunoassay), and End User (Hospitals, Diagnostics Laboratories, POC Testing, Forensic Laboratories, and Others)
Antibody/Substrate Reagent Segment to Dominate North America Acetaminophen Reagents Market During 2021–2028
According to a new market research study on “North America Acetaminophen Reagents Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Application, and End User” is expected to reach US$ 292.28 million by 2028 from US$ 205.24 million in 2021. The market is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The report provides trends prevailing in the North America acetaminophen reagents market along with the drivers and restraints pertaining to the market growth. Growing incidence of drugs overdose and rising adoption of acetaminophen testing are the major factor driving the growth of the North America acetaminophen reagents market. However, growing risk of ADHD and other complication in pregnancy hinder the growth of North America acetaminophen reagents market.
In case of COVID-19, North America is highly affected specially the US. North America witnessed growing number of COVID-19 cases since its outbreak. North America is one of the most important regions for adopting and growing new technologies due to flattering government policies to boost innovation, a vast industrial base, and high purchasing power, mainly in developed countries such as the US and Canada. Hence, any impact on the industries operations’ affects the region's economic growth. As a result, healthcare systems were overburdened, and the delivery of medical care to all patients became a challenge in the region and the sudden surge in number of infections led to shortage of emergency health supplies. In order to manage the outbreak, government took preventive measures including countrywide lockdowns and social distancing policies. In addition, pharmaceuticals and medical device industry faced negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, the companies faced difficulties in managing their operations. Many companies offering acetaminophen reagents having their business operations in the United States were severely impacted due to disrupted and restricted company’s ability to distribute products, as well as temporary closures of facilities. Moreover, market players also witnessed disruption in their business operations, slumped demand for products had marginal negative impact on the North America acetaminophen reagents market.
The North America acetaminophen reagents market has been segmented based on product, application, end user, and country. Based on product, the market has been segmented into antibody/substrate reagent, enzyme reagent, acetaminophen antiserum, acetaminophen fluorescein tracer, and pretreatment solution. The antibody/substrate reagent segment dominated the market in 2020 and enzyme reagent segment is expected to be fastest growing during forecast period. Based on application, the market has been segmented as enzymatic assays and immunoassay. The enzymatic assays segment dominated the market in 2020 and immunoassay segment is expected to be fastest growing during forecast period. Based on end user, the market has been segmented into hospitals, diagnostics laboratories, POC testing, forensic laboratories, and others. The hospitals segment dominated the market in 2020 and diagnostics laboratories segment is expected to be fastest growing during forecast period. Based on country, the market has been segmented into the US, Canada, and Mexico.
Abbott; American Screening Corporation, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Biorbyt Ltd.; EKF Diagnostics; Randox Laboratories, Ltd.; Sekisui Diagnostics; Siemens Healthineers AG; and Thermo Fisher Scientific Inc. are among the leading companies in the North America acetaminophen reagents market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of the companies' long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis products including a multi-year extension.
Contact Person: Sameer Joshi
Email Id: email@example.com